Ad
related to: BioNTech and Pfizer- Schedule A Vaccine
Book A Vaccine Appointment
Today At A Location Near You.
- Take Eligibility Quiz
Check Your Eligibility For Vaccines
That May Help Protect You.
- Schedule A Vaccine
Search results
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 19 hours ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Morningstar· 5 hours agoOrganizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1 ...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 21 hours agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Oracle, Moderna, Palantir Technologies And A Big Bank On CNBC’s ‘Final Trades’ - Oracle (NYSE:ORCL)
Benzinga· 1 day agoOn CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Oracle Corporation...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 21 hours agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
The West should be on a war footing for the next pandemic
The Telegraph via Yahoo News· 24 hours agoPeople have been quick to forget how bad the pandemic was, but it’s important to remember the scale...
Vaccine makers receive stock boost after third human bird flu case in US
Newsweek· 2 hours agoShares in some companies that produce vaccines have seen stock boosts following a small number of...
Health Care Up as Vaccine Makers Gain - Health Care Roundup
Market Watch· 19 hours agoHealth-care companies rose as reported cases of bird flu in Australia and the U.S. buoyed vaccine makers. Shares of CureVac, BioNTech and Moderna rose by 10%...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 6 days ago/BioNTech SE. The investment firm, which owns approximately 6.8% of Arbutus, also called for a...
Nvidia Rocks, Stocks Lost in the Light, Fed Minutes Takeaways, Solomon's Song
TheStreet.com· 5 hours agoMarkets appeared to be less than fully prepared that 'various [Fed] participants' had at least...
Ad
related to: BioNTech and Pfizer